Developer docs
API playgroundTry for free, no card

Search company profiles

Apex Formulations Pvt. Ltd. - India

Full company profile

uuid003vuke

Namestring
Apex Formulations Pvt. Ltd. - India
Legal namestring
Apex Formulations Pvt. Ltd.
Company typeenum
Private
Founded yearint
1998
Descriptiontext

Apex Formulations Pvt. Ltd. is an Ahmedabad-headquartered, privately held Indian pharmaceutical manufacturer founded in 1998, operating a WHO GMP, GLP, and ISO 9001-2015 certified production facility in Mehsana, Gujarat. The company's core technology is conventional generic pharmaceutical manufacturing across four dosage forms — Tablets, Capsules, Liquid Orals, and Skin Creams and Ointments — with a 250+ product portfolio spanning cardiovascular, neurological, anti-infective, and metabolic therapeutic categories. It also offers SR and ER modified-release solid oral presentations, capsule variants, suspensions/solutions, and topical dermatologicals. The underlying operations rely on audited manufacturing processes and quality systems rather than proprietary technology platforms, and the firm holds no disclosed patents or trademarks.

The business model is multi-channel B2B distribution built around six revenue streams: (1) international export of 150+ registered products to 20+ countries across South East Asia, Africa, Latin/Central America, and CIS via merchant exporters; (2) domestic distribution through a PCD (Propaganda Cum Distribution) franchise network covering 17+ Indian states; (3) direct supply to State Governments via tender; (4) third-party/contract manufacturing; (5) loan license manufacturing for other brands; and (6) CMO licensing and distribution partnerships internationally. Pricing is not publicly disclosed and is established through direct B2B inquiry. The company employs 100+ qualified staff, holds 10+ industry awards/accreditations, and operates as a single integrated manufacturing entity with no subsidiaries, no external funding history, and no public listing.

Short descriptiontext

Apex Formulations is an Indian WHO GMP-certified generic pharmaceutical manufacturer (founded 1998) producing 250+ products across four dosage forms in Gujarat and distributing them via merchant exporters to 20+ countries, a PCD network across 17+ Indian states, government tenders, and contract manufacturing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAhmedabad, India
HQ citystring
Ahmedabad
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
generic pharmaceutical manufacturing, finished dosage formulations, contract manufacturing services, PCD pharma distribution, pharmaceutical exports
Industry2 codes
1Generic ANDA/Regulatory Affairs & Submissions
CodeHLAIABAJPrimaryYes
2Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor)
CodeHLAIAJAFPrimaryNo
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Generic Pharmaceutical Manufacturing
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model6 records
1Domestic Product Sales
TypeOne Time License
Description

Manufacturing and distribution of pharmaceutical finished formulations to the Indian domestic market through PCD business partners across 17+ states

apexformulations.com
2International Export Sales
TypeOne Time License
Description

Supply of 150+ registered products to 20+ countries through merchant exporters across South East Asia, Africa, Latin/Central America and CIS regions

apexformulations.com
3PCD Business Partnership
TypeOne Time License
Description

Partnership-based distribution model for marketing pharmaceutical products through PCD (Propaganda Cum Distribution) franchise network

apexformulations.com
4Third Party Manufacturing
TypeOne Time License
Description

Contract manufacturing services for other pharmaceutical companies requiring manufacturing capabilities

apexformulations.com
5Government Supply
TypeOne Time License
Description

Supply of pharmaceutical finished formulations to various State Governments through tender/business contracts

apexformulations.com
6Loan License Business
TypeOne Time License
Description

Manufacturing under loan license arrangements for other pharmaceutical brands

apexformulations.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Apex Formulations manufactures generic pharmaceutical finished formulations in Tablets, Capsules, Liquid Orals, Skin Creams, and Ointments at a WHO GMP, GLP, and ISO 9001-2015 certified facility in Gujarat, India. The company sells its 250+ product portfolio domestically through PCD franchise partners across 17+ Indian states and State Government tenders, and internationally through merchant exporters across 20+ countries. It also provides contract manufacturing (third-party / loan license) services to other pharmaceutical companies.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Apex Formulations Pvt. Ltd. is a pharmaceutical manufacturing company established in 1998 that operates as a single unified business rather than a platform-plus-modules architecture. The company manufactures and distributes generic pharmaceutical finished formulations across two primary channels: Export Pharmaceuticals (serving 20+ countries via merchant exporters with 150+ registered products) and Domestic Pharmaceuticals (serving 17+ states in India through PCD businesses and government tenders). The manufacturing portfolio encompasses four dosage forms — Tablets, Capsules, Liquid Orals, and Skin Creams and Ointments — supported by contract/third-party manufacturing services and loan license arrangements. The company employs over 100 qualified staff and has received 10+ awards and accreditations.

Product and service8 records
1Export Pharmaceuticals
CategoryPharmaceutical product line (international)
Description

Apex Formulations' international export product line of pharmaceutical finished formulations supplied to 20+ countries across South East Asia, Africa, Latin/Central America, and CIS regions through merchant exporters, comprising 150+ registered products.

2Domestic Pharmaceuticals (India)
CategoryPharmaceutical product line (domestic)
Description

Apex Formulations' domestic Indian product line of pharmaceutical finished formulations distributed to 17+ states through PCD (Propaganda Cum Distribution) business partners and supplied directly to various State Governments via tender business.

3Tablets
CategoryPharmaceutical dosage form (oral solid)
Description

Apex manufactures tablet formulations including SR (sustained release), ER (extended release), and standard tablets across therapeutic categories such as cardiovascular, neurological, anti-infective, and metabolic disorders.

4Capsules
CategoryPharmaceutical dosage form (oral solid)
Description

Apex manufactures capsule formulations for various therapeutic applications, including modified-release and standard capsule presentations.

5Liquid Orals
CategoryPharmaceutical dosage form (oral liquid)
Description

Apex manufactures liquid oral dosage forms including suspensions and solutions for various therapeutic categories.

6Skin Creams and Ointments
CategoryPharmaceutical dosage form (topical)
Description

Apex manufactures topical dermatological products including skin creams and ointments for various therapeutic applications.

7Third Party / Contract Manufacturing
CategoryManufacturing services
Description

Contract manufacturing organization (CMO) and loan license manufacturing services offered by Apex Formulations to other pharmaceutical companies that require manufacturing capacity under WHO GMP certified quality standards.

8Government Tender Supply
CategoryGovernment procurement / institutional supply
Description

Direct supply of pharmaceutical finished formulations by Apex Formulations to various State Governments in India through government tender business / public procurement contracts.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Apex has partnered with Merchant Exporters to supply 150+ products registered in more than 20+ countries across South East Asia, Africa, Latin/Central America and CIS regions. This partnership enables international market reach for Apex's generic pharmaceutical products.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Indian pharmaceutical manufacturer offering contract manufacturing and generic formulations across dosage forms. Similar CMO-led, multi-dosage-form business profile with domestic and export reach.

TypeBroad incumbent
Description

Mid-large Indian generic pharmaceutical company with significant branded-generic presence in emerging markets (Africa, Asia, CIS). Comparable international footprint structure to Apex's 20+ country export reach, though at a larger scale.

TypeBroad incumbent
Description

Large Indian generic pharmaceutical manufacturer with extensive international operations including emerging markets. Comparable export + domestic generic manufacturing business model, though at substantially greater scale than Apex.

TypeDirect peer
Description

Indian generic pharmaceutical manufacturer with similar product portfolio and third-party manufacturing / domestic distribution model. Comparable mid-tier scale, though with less international export presence than Apex.

TypeBroad incumbent
Description

Major Indian pharmaceutical incumbent with extensive global footprint, multi-dosage-form manufacturing (including injectables/inhalables), and government-tender business. Comparable in therapeutic breadth and international reach category.

TypeBroad incumbent
Description

One of India's largest integrated pharmaceutical companies with multi-dosage-form manufacturing, WHO GMP facilities, and significant international presence. Broad incumbent operating in the same generic formulation space.

TypeDirect peer
Description

Indian contract manufacturer and generic formulations producer with strong third-party manufacturing, loan licensing, and domestic franchise distribution — closely mirroring Apex's CMO + PCD + domestic business mix.

TypeBroad incumbent
Description

India's largest domestic-focused generic pharma company with strong franchise/PCD-style distribution. Comparable domestic distribution model via partner networks across Indian states, but with a much larger branded-generic portfolio.

TypeDirect peer
Description

India's largest contract development and manufacturing organization (CDMO) producing a broad range of finished dosage forms. Highly comparable to Apex: WHO GMP certified, multi-dosage-form manufacturer with strong third-party manufacturing and domestic distribution model.

TypeDirect peer
Description

Ahmedabad-based Indian generic manufacturer with a similar mid-tier scale, PCD franchise distribution network across Indian states, and focus on domestic + export generics across multiple dosage forms.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Apex Formulations Pvt. Ltd. - India

Generic Pharmaceutical Manufacturingapexformulations.com

Apex Formulations is an Indian WHO GMP-certified generic pharmaceutical manufacturer (founded 1998) producing 250+ products across four dosage forms in Gujarat and distributing them via merchant exporters to 20+ countries, a PCD network across 17+ Indian states, government tenders, and contract manufacturing.

What Apex Formulations Pvt. Ltd. - India does

Apex Formulations Pvt. Ltd. is an Ahmedabad-headquartered, privately held Indian pharmaceutical manufacturer founded in 1998, operating a WHO GMP, GLP, and ISO 9001-2015 certified production facility in Mehsana, Gujarat. The company's core technology is conventional generic pharmaceutical manufacturing across four dosage forms — Tablets, Capsules, Liquid Orals, and Skin Creams and Ointments — with a 250+ product portfolio spanning cardiovascular, neurological, anti-infective, and metabolic therapeutic categories. It also offers SR and ER modified-release solid oral presentations, capsule variants, suspensions/solutions, and topical dermatologicals. The underlying operations rely on audited manufacturing processes and quality systems rather than proprietary technology platforms, and the firm holds no disclosed patents or trademarks.

The business model is multi-channel B2B distribution built around six revenue streams: (1) international export of 150+ registered products to 20+ countries across South East Asia, Africa, Latin/Central America, and CIS via merchant exporters; (2) domestic distribution through a PCD (Propaganda Cum Distribution) franchise network covering 17+ Indian states; (3) direct supply to State Governments via tender; (4) third-party/contract manufacturing; (5) loan license manufacturing for other brands; and (6) CMO licensing and distribution partnerships internationally. Pricing is not publicly disclosed and is established through direct B2B inquiry. The company employs 100+ qualified staff, holds 10+ industry awards/accreditations, and operates as a single integrated manufacturing entity with no subsidiaries, no external funding history, and no public listing.

Apex Formulations Pvt. Ltd. - India firmographics

Firmographics
Name
Apex Formulations Pvt. Ltd. - India
Legal name
Apex Formulations Pvt. Ltd.
Website
https://apexformulations.com
Company type
Private
Founded year
1998
Operating status
Operating
Headcount range
1–10 employees
Short description
Apex Formulations is an Indian WHO GMP-certified generic pharmaceutical manufacturer (founded 1998) producing 250+ products across four dosage forms in Gujarat and distributing them via merchant exporters to 20+ countries, a PCD network across 17+ Indian states, government tenders, and contract manufacturing.
Ownership category
akta.pro rank

Apex Formulations Pvt. Ltd. - India industry classification

Industry
Product category
Generic Pharmaceutical Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro primary industry
Generic ANDA/Regulatory Affairs & Submissions (HLAIABAJ)
akta.pro secondary industry
Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)

Keywords

  • Generic pharmaceutical manufacturing
  • Finished dosage formulations
  • Contract manufacturing services
  • PCD pharma distribution
  • Pharmaceutical exports

Where Apex Formulations Pvt. Ltd. - India is headquartered

Location

Headquarters

HQ city
Ahmedabad
HQ country
India
HQ region
Asia

Offices2 records

Markets served

Apex Formulations Pvt. Ltd. - India business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Domestic Product Sales: Manufacturing and distribution of pharmaceutical finished formulations to the Indian domestic market through PCD business partners across 17+ states
  2. International Export Sales: Supply of 150+ registered products to 20+ countries through merchant exporters across South East Asia, Africa, Latin/Central America and CIS regions
  3. PCD Business Partnership: Partnership-based distribution model for marketing pharmaceutical products through PCD (Propaganda Cum Distribution) franchise network
  4. Third Party Manufacturing: Contract manufacturing services for other pharmaceutical companies requiring manufacturing capabilities
  5. Government Supply: Supply of pharmaceutical finished formulations to various State Governments through tender/business contracts
  6. Loan License Business: Manufacturing under loan license arrangements for other pharmaceutical brands

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Apex Formulations Pvt. Ltd. - India product offering

Product offering

Core offering

Apex Formulations manufactures generic pharmaceutical finished formulations in Tablets, Capsules, Liquid Orals, Skin Creams, and Ointments at a WHO GMP, GLP, and ISO 9001-2015 certified facility in Gujarat, India. The company sells its 250+ product portfolio domestically through PCD franchise partners across 17+ Indian states and State Government tenders, and internationally through merchant exporters across 20+ countries. It also provides contract manufacturing (third-party / loan license) services to other pharmaceutical companies.

Product overview

Apex Formulations Pvt. Ltd. is a pharmaceutical manufacturing company established in 1998 that operates as a single unified business rather than a platform-plus-modules architecture. The company manufactures and distributes generic pharmaceutical finished formulations across two primary channels: Export Pharmaceuticals (serving 20+ countries via merchant exporters with 150+ registered products) and Domestic Pharmaceuticals (serving 17+ states in India through PCD businesses and government tenders). The manufacturing portfolio encompasses four dosage forms — Tablets, Capsules, Liquid Orals, and Skin Creams and Ointments — supported by contract/third-party manufacturing services and loan license arrangements. The company employs over 100 qualified staff and has received 10+ awards and accreditations.

Differentiator

Problem solved

Functional benefit

Products and services

  • Export Pharmaceuticals Apex Formulations' international export product line of pharmaceutical finished formulations supplied to 20+ countries across South East Asia, Africa, Latin/Central America, and CIS regions through merchant exporters, comprising 150+ registered products.
  • Domestic Pharmaceuticals (India) Apex Formulations' domestic Indian product line of pharmaceutical finished formulations distributed to 17+ states through PCD (Propaganda Cum Distribution) business partners and supplied directly to various State Governments via tender business.
  • Tablets Apex manufactures tablet formulations including SR (sustained release), ER (extended release), and standard tablets across therapeutic categories such as cardiovascular, neurological, anti-infective, and metabolic disorders.
  • Capsules Apex manufactures capsule formulations for various therapeutic applications, including modified-release and standard capsule presentations.
  • Liquid Orals Apex manufactures liquid oral dosage forms including suspensions and solutions for various therapeutic categories.
  • Skin Creams and Ointments Apex manufactures topical dermatological products including skin creams and ointments for various therapeutic applications.
  • Third Party / Contract Manufacturing Contract manufacturing organization (CMO) and loan license manufacturing services offered by Apex Formulations to other pharmaceutical companies that require manufacturing capacity under WHO GMP certified quality standards.
  • Government Tender Supply Direct supply of pharmaceutical finished formulations by Apex Formulations to various State Governments in India through government tender business / public procurement contracts.

Companies that use Apex Formulations Pvt. Ltd. - India

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Apex Formulations Pvt. Ltd. - India technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Apex Formulations Pvt. Ltd. - India partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Merchant ExporterscoreChannel Partner/ Reseller/ DistributorApex has partnered with Merchant Exporters to supply 150+ products registered in more than 20+ countries across South East Asia, Africa, Latin/Central America and CIS regions. This partnership enables international market reach for Apex's generic pharmaceutical products.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Apex Formulations Pvt. Ltd. - India competitors and assessment

Company assessment

Direct peers

  • Tirupati Medicare: Indian pharmaceutical manufacturer offering contract manufacturing and generic formulations across dosage forms. Similar CMO-led, multi-dosage-form business profile with domestic and export reach.
  • Acme Formulation: Indian generic pharmaceutical manufacturer with similar product portfolio and third-party manufacturing / domestic distribution model. Comparable mid-tier scale, though with less international export presence than Apex.
  • Synokem Pharmaceuticals: Indian contract manufacturer and generic formulations producer with strong third-party manufacturing, loan licensing, and domestic franchise distribution — closely mirroring Apex's CMO + PCD + domestic business mix.
  • Akums Drugs & Pharmaceuticals: India's largest contract development and manufacturing organization (CDMO) producing a broad range of finished dosage forms. Highly comparable to Apex: WHO GMP certified, multi-dosage-form manufacturer with strong third-party manufacturing and domestic distribution model.
  • Unison Pharmaceuticals: Ahmedabad-based Indian generic manufacturer with a similar mid-tier scale, PCD franchise distribution network across Indian states, and focus on domestic + export generics across multiple dosage forms.

Broad incumbents

  • Ajanta Pharma: Mid-large Indian generic pharmaceutical company with significant branded-generic presence in emerging markets (Africa, Asia, CIS). Comparable international footprint structure to Apex's 20+ country export reach, though at a larger scale.
  • Aurobindo Pharma: Large Indian generic pharmaceutical manufacturer with extensive international operations including emerging markets. Comparable export + domestic generic manufacturing business model, though at substantially greater scale than Apex.
  • Cipla: Major Indian pharmaceutical incumbent with extensive global footprint, multi-dosage-form manufacturing (including injectables/inhalables), and government-tender business. Comparable in therapeutic breadth and international reach category.
  • Cadila Pharmaceuticals (Zydus): One of India's largest integrated pharmaceutical companies with multi-dosage-form manufacturing, WHO GMP facilities, and significant international presence. Broad incumbent operating in the same generic formulation space.
  • Mankind Pharma: India's largest domestic-focused generic pharma company with strong franchise/PCD-style distribution. Comparable domestic distribution model via partner networks across Indian states, but with a much larger branded-generic portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Apex Formulations Pvt. Ltd. - India social profiles

Digital presence

Apex Formulations Pvt. Ltd. - India financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Apex Formulations Pvt. Ltd. - India leadership team

Management profile

Number of profiles

Apex Formulations Pvt. Ltd. - India funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Apex Formulations Pvt. Ltd. - India M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Apex Formulations Pvt. Ltd. - India

What does Apex Formulations Pvt. Ltd. - India do?

Apex Formulations manufactures generic pharmaceutical finished formulations in Tablets, Capsules, Liquid Orals, Skin Creams, and Ointments at a WHO GMP, GLP, and ISO 9001-2015 certified facility in Gujarat, India. The company sells its 250+ product portfolio domestically through PCD franchise partners across 17+ Indian states and State Government tenders, and internationally through merchant exporters across 20+ countries. It also provides contract manufacturing (third-party / loan license) services to other pharmaceutical companies.

Is Apex Formulations Pvt. Ltd. - India a public or private company?

Apex Formulations Pvt. Ltd. - India is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Apex Formulations Pvt. Ltd. - India founded?

Apex Formulations Pvt. Ltd. - India was founded in 1998. It employs 1 to 10 people.

Where is Apex Formulations Pvt. Ltd. - India based?

Apex Formulations Pvt. Ltd. - India is headquartered in Ahmedabad, India, in the Asia region.

How does Apex Formulations Pvt. Ltd. - India make money?

Six revenue lines are on record. Domestic Product Sales are the primary driver. The others are international Export Sales, PCD Business Partnership, third Party Manufacturing, government Supply and loan License Business.

Who are Apex Formulations Pvt. Ltd. - India's main competitors?

Direct peers on record are Tirupati Medicare, Acme Formulation, Synokem Pharmaceuticals, Akums Drugs & Pharmaceuticals and Unison Pharmaceuticals. Broad incumbents are Ajanta Pharma, Aurobindo Pharma, Cipla, Cadila Pharmaceuticals (Zydus) and Mankind Pharma.

Does Apex Formulations Pvt. Ltd. - India have an API?

No public API is recorded for Apex Formulations Pvt. Ltd. - India.

What industry is Apex Formulations Pvt. Ltd. - India in?

Apex Formulations Pvt. Ltd. - India's product category is Generic Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIABAJ, Generic ANDA/Regulatory Affairs & Submissions, with a secondary code of HLAIAJAF, Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales